Related content

A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis

By Okita Kiwamu   Sakaida Isao   Okada Mitsuru   Kaneko Akira   Chayama Kazuaki   Kato Michio   Sata Michio   Yoshihara Naomasa   Ono Noriyuki   Murawaki Yoshikazu  

Journal of Gastroenterology, Vol. 45, Iss. 9, 2010-09 ,pp. : 979-987

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of Indacaterol, a New 24-hour β 2-Agonist, in Patients with Asthma: A Dose-Ranging Study

By Kanniess Frank   Boulet Louis-Philippe   Pierzchala Wladyslaw   Cameron Ray   Owen Roger   Higgins Mark  

Journal of Asthma, Vol. 45, Iss. 10, 2008-12 ,pp. : 887-892

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Safety and Efficacy of Donepezil in Patients with Severe Alzheimer’s Disease: Results from a 52-Week, Open-Label, Multicenter, Extension Study in Japan

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 3, 2009-02 ,pp. : 232-239

Karger

Access to resources Recommend Favorite

Long-Term Safety and Efficacy of Donepezil in Patients with Dementia with Lewy Bodies: Results from a 52-Week, Open-Label, Multicenter Extension Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 36, Iss. 3-4, 2013-08 ,pp. : 229-241

Karger

Access to resources Recommend Favorite

Safety, Pharmacokinetics and Biological Activity of Enlimomab (Anti-ICAM-1 Antibody): An Open-Label, Dose Escalation Study in Patients Hospitalized for Acute Stroke

By  

European Neurology, Vol. 40, Iss. 2, 1998-08 ,pp. : 78-83

Karger

Access to resources Recommend Favorite